REGENTS OF THE UNIVERSITY OF CALIFORNIA - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 84 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
REGENTS OF THE UNIVERSITY OF CALIFORNIA ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2020$2,679,000
+5.1%
620,2330.0%0.39%
+9.3%
Q3 2020$2,549,000
-50.1%
620,233
-27.1%
0.35%
-50.6%
Q2 2020$5,107,000851,2010.72%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders